Log in  First Connection?

VaccinesArchives

Using protection motivation theory to explain monkeypox vaccination intention among men who have sex with men in China
Vaccines
 6 min.

 Published on 11/12/2025 |  Original article (Full-text)  | Xu Chen et al. | BMC Medicine 2025; 23(1): 652

Monkeypox (Mpox) is a zoonotic disease caused by the Mpox virus (MPXV), which has a clinical presentation similar to smallpox. A human case was first detected in 1970 in the Democratic Republic of Congo [1]. Since its discovery, the disease has remained endemic in Central and Western Africa [2]. There...

A cluster randomised trial of digital messaging nudges to improve influenza vaccination uptake in China
Vaccines
 7 min.

 Published on 04/12/2025 |  Original article (Full-text)  | Wang Qian et al. | npj Digital Medicine 2025; 8(1): 725

Seasonal influenza is a significant public health problem globally, particularly for children1. Approximately 28,000 children under 18 years old die annually from influenza-associated lower respiratory infections, with the majority being under four years old2. Despite being the most effective measure...

Safety, immunogenicity, persistence and dose evaluation of the CS-2034 mRNA COVID-19 vaccine: a phase II randomized controlled trial in healthy Chinese adults
Vaccines
 7 min.

 Published on 27/11/2025 |  Original article (Full-text)  | Jin Zhili et al. | BMC Infectious Diseases 2025; 25(1): 1625

SARS-CoV-2 is an extremely contagious single-stranded RNA virus that has rapidly spread worldwide, causing COVID-19. Vaccination has been pivotal in mitigating its impact. Although mRNA vaccine technology is relatively new, it offers distinct advantages over other vaccine platforms, including rapid manufacturing,...

Long-term trends in reporting of cardiac adverse drug reactions to COVID-19 vaccines - an exploratory analysis of the EudraVigilance database
Vaccines
 6 min.

 Published on 20/11/2025 |  Original article (Full-text)  | Nazar Wojciech et al. | BMC Infectious Diseases 2025; 25(1): 1584

Vaccines against Coronavirus disease 2019 (COVID-19) are confirmed to be highly effective in preventing COVID-19 infections [1, 2, 3–4]. Vaccinating reduces the risk of symptomatic infection, hospitalisations, including in intensive care units, and death [1, 2, 3, 4–5]. The European Medicines...

Ageing with HIV-1: immunological challenges for effective vaccination
Vaccines
 5 min.

 Published on 13/11/2025 |  Original article (Full-text)  | Saint-Charles Pauline et al. | Immunity & Ageing 2025; 22(1): 48

By 2050, the proportion of the world’s population aged 60 and above is expected to increase from 12% to 22%, and the number of people over 80 years old is projected to triple between 2020 and 2050 [1]. These estimations illustrate the need to address ageing as a significant public health issue...